| Hang Seng Index | 25.000 HKD | +0.020 | +0.080% | 509.14M | 12.75B | 24.695 (+1.235%) HKD as at 2025/07/14 | | |
| Hang Seng China Enterprises | 90.760 HKD | +0.080 | +0.088% | 75.22M | 6.83B | 89.405 (+1.516%) HKD as at 2025/07/14 | | |
| Hang Seng TECH Index | 5.355 HKD | +0.025 | +0.469% | 940.76M | 5.02B | 5.192 (+3.141%) HKD as at 2025/07/14 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng TECH Index | 5.365 HKD | +0.055 | +1.036% | 155.04M | 830.30M | 5.068 (+5.858%) HKD as at 2025/07/14 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng TECH Index | 1.628 HKD | -0.014 | -0.853% | 322.21M | 525.33M | 1.730 (-5.874%) HKD as at 2025/07/14 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng Index | 5.490 HKD | -0.005 | -0.091% | 31.42M | 173.13M | 5.352 (+2.580%) HKD as at 2025/07/14 | | |
| Hang Seng TECH Index | 11.460 HKD | +0.060 | +0.526% | 14.86M | 170.36M | 11.055 (+3.664%) HKD as at 2025/07/11 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng Index | 2.122 HKD | +0.002 | +0.094% | 74.74M | 158.05M | 2.179 (-2.607%) HKD as at 2025/07/14 | | |
| CSI Hong Kong Dividend | 36.860 HKD | -0.460 | -1.233% | 4.01M | 148.51M | 37.299 (-1.178%) HKD as at 2025/07/14 | | |
| Hang Seng China Enterprises | 10.690 HKD | +0.010 | +0.094% | 9.06M | 96.81M | 10.522 (+1.601%) HKD as at 2025/07/11 | | |
| Hang Seng TECH Index | 5.430 HKD | +0.025 | +0.463% | 17.03M | 92.37M | 5.236 (+3.709%) HKD as at 2025/07/11 | | |
| Hang Seng Hong Kong-Listed Biotech Index | 15.750 HKD | +0.790 | +5.281% | 4.70M | 73.37M | 14.384 (+9.497%) HKD as at 2025/07/14 | | |
| MSCI Asia APEX 50 | 64.140 HKD | +0.320 | +0.501% | 1.02M | 65.75M | 63.345 (+1.255%) HKD as at 2025/07/11 | | |
| CSI 300 | 45.920 HKD | +0.100 | +0.218% | 891.37K | 40.87M | 45.925 (-0.011%) HKD as at 2025/07/14 | | |
| FTSE US Treasury 20+ Years Index | 67.160 HKD | -0.180 | -0.267% | 577.53K | 38.83M | 67.851 (-1.018%) HKD as at 2025/07/11 | | |
| FTSE China A50 | 14.600 HKD | 0.000 | 0.000% | 2.45M | 35.77M | 14.712 (-0.763%) HKD as at 2025/07/11 | | |
| CSI 300 | 29.780 HKD | +0.260 | +0.881% | 1.09M | 32.51M | 29.640 (+0.474%) HKD as at 2025/07/11 | | |
| CME Ether Futures | 16.520 HKD | +1.340 | +8.827% | 1.54M | 24.54M | 14.410 (+14.643%) HKD as at 2025/07/11 | | |
| Hang Seng High Dividend Yield | 28.920 HKD | -0.060 | -0.207% | 735.50K | 21.27M | 28.837 (+0.289%) HKD as at 2025/07/11 | | |
| London Gold Fixing Price | 2,405.000 HKD | -8.000 | -0.332% | 8.47K | 20.43M | N/A | | |
| CME CF Ether-Dollar Reference Rate - Asia Pacific Variant | 8.290 HKD | +0.690 | +9.079% | 2.50M | 20.29M | 7.296 (+13.629%) HKD as at 2025/07/14 | | |
| CME CF Bitcoin Reference Rate- Asia Pacific Variant | 9.215 HKD | +0.020 | +0.218% | 1.88M | 17.29M | 9.526 (-3.264%) HKD as at 2025/07/14 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | NASDAQ-100 Index | 3.942 HKD | -0.050 | -1.253% | 3.72M | 14.67M | 3.998 (-1.398%) HKD as at 2025/07/11 | | |
| FTSE China A50 | 13.600 HKD | 0.000 | 0.000% | 1.02M | 13.94M | 13.728 (-0.933%) HKD as at 2025/07/14 | | |
| CME CF Bitcoin Reference Rate- Asia Pacific Variant | 14.680 HKD | +0.050 | +0.342% | 675.20K | 9.89M | 15.166 (-3.205%) HKD as at 2025/07/14 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | CSI 300 | 3.814 HKD | +0.052 | +1.382% | 2.54M | 9.68M | 3.830 (-0.405%) HKD as at 2025/07/14 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng China Enterprises | 3.408 HKD | -0.004 | -0.117% | 2.69M | 9.19M | 3.311 (+2.920%) HKD as at 2025/07/14 | | |
| CSI China Reform Hong Kong Connect Central-SOEs High Dividend Yield Index | 9.615 HKD | -0.060 | -0.620% | 928.50K | 8.93M | 9.610 (+0.049%) HKD as at 2025/07/14 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Solactive Gold 1-Day Rolling Futures Index | 16.850 HKD | -0.120 | -0.707% | 464.40K | 7.87M | 17.182 (-1.932%) HKD as at 2025/07/11 | | |
| Hong Kong Interbank Offered Rate | 1,160.150 HKD | 0.000 | 0.000% | 6.55K | 7.60M | 1,159.812 (+0.029%) HKD as at 2025/07/14 | | |